Predictors of long-term risk for heart failure hospitalization after acute myocardial infarction

Juha S Perkiömäki1, Sari Hämekoski, M Juhani Junttila

  • 1Department of Medicine, University of Oulu, Finland. juha.perkiomaki@oulu.fi

Insights

Baseline brain natriuretic peptide (BNP) and autonomic markers like heart rate variability (HRV) significantly predict heart failure hospitalization after acute myocardial infarction (AMI). These markers offer valuable long-term risk information for patients post-AMI.

Area of Science:

  • Cardiology
  • Biomarkers
  • Autonomic Nervous System Function

Background:

  • Limited data exists on predicting heart failure (HF) hospitalization post-acute myocardial infarction (AMI).
  • Baseline brain natriuretic peptide (BNP) and autonomic markers' predictive value for HF hospitalization after AMI is not well-established.

Purpose of the Study:

  • To investigate the predictive value of baseline brain natriuretic peptide (BNP) and autonomic markers for heart failure (HF) hospitalization.
  • To assess the long-term risk stratification capabilities of these markers in patients following an acute myocardial infarction (AMI).

Main Methods:

  • Prospective follow-up of 569 patients with AMI without prior HF for 8 years.
  • Baseline assessment included BNP levels, 24-hour Holter monitoring for heart rate variability (HRV) and heart rate turbulence (HRT), and baroreflex sensitivity (BRS) testing.
  • Statistical analysis including univariate and multivariate comparisons and receiver operator characteristic (ROC) curve analysis.

Main Results:

  • Increased baseline BNP, decreased HRV, HRT, and BRS were significantly associated with HF hospitalization.
  • BNP, HRV (short-term scaling exponent alpha(1)), and HRT (turbulence slope) remained significant predictors after adjusting for clinical parameters.
  • ROC analysis showed areas under the curve for BNP (0.77), alpha(1) (0.69), turbulence slope (0.71), and BNP/SDNN ratio (0.80).

Conclusions:

  • Elevated baseline BNP and impaired autonomic function post-AMI provide significant information for long-term HF hospitalization risk.
  • These markers aid in identifying patients at higher risk for future heart failure events after myocardial infarction.
  • The findings support the utility of BNP and autonomic function tests in risk stratification following AMI.
Abstract

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...